American Enterprise Institute for Public Policy Research
Comparative Effectiveness Research: The Need for a Uniform Standard
June 2009
Reconciling a new comparative effectiveness research (CER) agency with scientific standards established in existing regulations would enable government agencies to share a consistent framework for making decisions based on CER. It would provide the kind of level playing field and clear guidelines that are needed to spur medical product developers and private payers to generate more of their own comparative evidence.
Reprinted with the permission of the American Enterprise Institute for Public Policy Research, Washington, D.C.
Capabilities
Suggested News & Insights
GMP 2026: Regulatory Reliance, AI, and the Future of Pharmaceutical ManufacturingWednesday, December 2, 2026FDA Announces Rare Disease Framework Initiative to Foster Consistent Review Approach Tailored to Unique Drug Development Considerations for Rare DiseasesOctober 20, 2026Sidley Represents Strategic Partnership Between Silgan and AIP in US$7.3 Billion Transaction to Create Diversified Global Metal Packaging BusinessOctober 19, 20262026 Momentum Food and Beverage ExchangeOctober 6-7, 2026Sidley Represents GE HealthCare in Its US$945 Million Acquisition of SOFIE BiosciencesOctober 7, 2026Sidley Represents Telix Pharmaceuticals in Its US$1.65 Billion Merger With ITMOctober 5, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory